Logo FutureDocs
  • HOME
  • OUR PLATFORM
  • DOCTORS
  • PHARMA/PAYERS
  • ABOUT
  • NEWS
  • CONTACT

May, 2019. ConsultorioMOVIL signs technology deal with Novartis Chile and RedSalud to deploy and launch Migraine-oriented breakthru Patient & Physician Digital Ecosystem for new pharma’s product launching

14 November, 2019
-
News
-
Posted by futuredocs

← PREVIOUS POST
July 2019. ConsultorioMOVIL partners with Medical Societies, Universities and Pharma to offer it’s free Innovation Program’s seminars for Physicians
NEXT POST →
April 2019. ConsultorioMOVIL partners with Novartis Mexico to offer it’s free Innovation Program’s seminars for Physicians

Related News

Other posts that you should not miss.

March 2018. ConsultorioMOVIL launches its Real World Evidence (RWE) features within its EHR platform, to empower its specialists & users’ abilities to develop research and publication activities

14 November, 2019
-
News
Read More →
Posted by futuredocs
1 MIN READ
Congreso nefro 2015

ConsultorioMOVIL closes “Digital Innovation Program 2015” for Physicians in leading medical congresses thru all the country

20 November, 2015
-
News

ConsultorioMOVIL closes “Digital Innovation Program 2015” for Physicians in leading medical congresses thru all the country Events and seminars were offered to thousands of physicians and specialists in …

Read More →
Posted by futuredocs
1 MIN READ

November 2018. ConsultorioMOVIL launches it’s operations in Mexico and debuts in ANCAM Annual Cardiology Congress

14 November, 2019
-
News
Read More →
Posted by futuredocs
1 MIN READ

FutureDocs, ConsultorioMOVIL, ConsultorioMOVEL are trademarks © Copyright 2019 FutureDocs LLC.

(*) Sources: Manhattan Research, Taking the Pulse, FICO Research Global Survey. Research2Guidance, mHealth Economics, IQVIA “The Growing Value of Digital Health” report

Realizado por Think B

May, 2019. ConsultorioMOVIL signs technology deal with Novartis Chile and RedSalud to deploy and launch Migraine-oriented breakthru Patient & Physician Digital Ecosystem for new pharma’s product launching | FutureDocs